Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources


Compound category: Amino acids, peptides, and analogues
(total 115 related compounds in database, current show from 31 to 40)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
Compound 12
(internal name in literature)		 Depiction based on curated SMILES O F F NH CH 3 S NH N OH O Chlamydia TTSS (Type III secretion system) Preclinical (in vitro) Zigangirova NA, et al. 2012. Acta Naturae
Compound 13
(internal name in literature)		 Depiction based on curated SMILES S HO OH N N H O F F N H Chlamydia TTSS (Type III secretion system) Preclinical (in vitro) Zigangirova NA, et al. 2012. Acta Naturae
Compound 14
(internal name in literature)		 Depiction based on curated SMILES HN OH F F CH 3 O S HN N O Chlamydia TTSS (Type III secretion system) Preclinical (in vitro) Zigangirova NA, et al. 2012. Acta Naturae
Compound 15
(internal name in literature)		 Depiction based on curated SMILES O F F F NH CH 3 S NH N OH O Chlamydia TTSS (Type III secretion system) Preclinical (in vitro) Zigangirova NA, et al. 2012. Acta Naturae
(2R,3R)-2-[[3-(2-chlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide Depiction based on curated SMILES OH N H O Cl CH 3 O O S N H H H 3 C Clostridium BoNT (Botulinum neurotoxin) Preclinical (in vitro) Thompson JC, et al. 2020. Bioorg Med Chem
(2S,3S)-2-[[3-(2,4-dichlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide Depiction based on curated SMILES OH N H O Cl Cl H 3 C O O S HN CH 3 Clostridium BoNT (Botulinum neurotoxin) Preclinical (in vitro) Thompson JC, et al. 2020. Bioorg Med Chem
(2S,3S)-2-[[3-(2,5-dichlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide Depiction based on curated SMILES OH N H O Cl Cl H 3 C O O S HN CH 3 Clostridium BoNT (Botulinum neurotoxin) Preclinical (in vitro) Thompson JC, et al. 2020. Bioorg Med Chem
(2S,3S)-2-[[3-(2,6-dichlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide Depiction based on curated SMILES OH N H O Cl Cl H 3 C O O S HN CH 3 Clostridium BoNT (Botulinum neurotoxin) Preclinical (in vitro) Thompson JC, et al. 2020. Bioorg Med Chem
(2S,3S)-2-[[3-(2-chlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide Depiction based on curated SMILES OH N H O Cl H 3 C O O S HN CH 3 Clostridium BoNT (Botulinum neurotoxin) Preclinical (in vitro) Thompson JC, et al. 2020. Bioorg Med Chem
(2S,3S)-2-[[3-(3,4-dichlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide Depiction based on curated SMILES OH N H O Cl Cl H 3 C O O S HN CH 3 Clostridium BoNT (Botulinum neurotoxin) Preclinical (in vitro) Thompson JC, et al. 2020. Bioorg Med Chem
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page  1  2  3  4  5  6  7  8  9  10  11  12 



Back to top
2004-2024 NIPB, CAMS&PUMC